Ute Egerland

907 total citations
27 papers, 664 citations indexed

About

Ute Egerland is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Ute Egerland has authored 27 papers receiving a total of 664 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 10 papers in Organic Chemistry and 8 papers in Pharmacology. Recurrent topics in Ute Egerland's work include Phosphodiesterase function and regulation (15 papers), Receptor Mechanisms and Signaling (8 papers) and Cholinesterase and Neurodegenerative Diseases (7 papers). Ute Egerland is often cited by papers focused on Phosphodiesterase function and regulation (15 papers), Receptor Mechanisms and Signaling (8 papers) and Cholinesterase and Neurodegenerative Diseases (7 papers). Ute Egerland collaborates with scholars based in Germany, Austria and Russia. Ute Egerland's co-authors include Chris Rundfeldt, Christian Grunwald, Barbara Langen, Rita Dost, Klaus Unverferth, Thorsten Hage, Hans‐Joachim Lankau, Nicholas J. Brandon, Michael S. Malamas and Karen L. Marquis and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and Molecules.

In The Last Decade

Ute Egerland

26 papers receiving 630 citations

Peers

Countries citing papers authored by Ute Egerland

Since Specialization

Citations

This map shows the geographic impact of Ute Egerland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ute Egerland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ute Egerland more than expected).

Fields of papers citing papers by Ute Egerland

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ute Egerland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ute Egerland. The network helps show where Ute Egerland may publish in the future.

Co-authorship network of co-authors of Ute Egerland

This figure shows the co-authorship network connecting the top 25 collaborators of Ute Egerland. A scholar is included among the top collaborators of Ute Egerland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ute Egerland. Ute Egerland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Investigation of an 18F-labelled Imidazopyridotriazine for Molecular Imaging of Cyclic Nucleotide Phosphodiesterase 2A 2018 ·Molecules ·(unknown), Barbara Wenzel, Winnie Deuther‐Conrad, Rodrigo Teodoro, Mathias Kranz, Matthias Scheunemann, Ute Egerland, (unknown), (unknown), Jörg Steinbach, Peter Brust	7
2	Development of highly potent phosphodiesterase 10A (PDE10A) inhibitors: Synthesis and in vitro evaluation of 1,8-dipyridinyl- and 1-pyridinyl-substituted imidazo[1,5-a]quinoxalines 2015 ·European Journal of Medicinal Chemistry ·(unknown), Matthias Scheunemann, (unknown), Ute Egerland, (unknown), Jörg Steinbach, Peter Brust	11
3	Synthesis, 18F-Radiolabelling and Biological Characterization of Novel Fluoroalkylated Triazine Derivatives for in Vivo Imaging of Phosphodiesterase 2A in Brain via Positron Emission Tomography 2015 ·Molecules ·(unknown), Barbara Wenzel, Winnie Deuther‐Conrad, Rodrigo Teodoro, Ute Egerland, Mathias Kranz, Matthias Scheunemann, (unknown), Jörg Steinbach, Peter Brust	14
4	Fluorine‐Containing 6,7‐Dialkoxybiaryl‐Based Inhibitors for Phosphodiesterase 10 A: Synthesis and in vitro Evaluation of Inhibitory Potency, Selectivity, and Metabolism 2014 ·ChemMedChem ·(unknown), (unknown), (unknown), Lenka Kubicová, Uta Funke, Ute Egerland, Michael Zahn, K Nieber, Matthias Scheunemann, Norbert Sträter, Peter Brust, (unknown)	11
5	Discovery of triazines as potent, selective and orally active PDE4 inhibitors 2013 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Christian Grunwald, Ute Egerland	33
6	Phosphodiesterase 2 Inhibitors Promote Axonal Outgrowth in Organotypic Slice Co-Cultures 2012 ·Neurosignals ·(unknown), (unknown), Nico Scherf, A. Berndt, Ute Egerland, Thorsten Hage, Heike Franke	14
7	Synthesis and structure–activity relationship studies of dihydronaphthyridinediones as a novel structural class of potent and selective PDE7 inhibitors 2011 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), (unknown), Christian Grunwald, Ute Egerland, (unknown)	17
8	Effect of PDE10A inhibitors on MK-801-induced immobility in the forced swim test 2011 ·Psychopharmacology ·Barbara Langen, Rita Dost, Ute Egerland, Hans Stange, (unknown)	29
9	ChemInform Abstract: 5‐(4‐Hydroxy‐6‐methyl‐2‐oxo‐2H‐pyran‐3‐yl) ‐7‐phenyl‐2,3,6,7‐tetrahydro‐1,4‐thiazepines as Compounds with High Affinity at the Benzodiazepine Binding Site on GABA_A Receptors. 2011 ·ChemInform ·Christian Grunwald, (unknown), Ute Egerland, R Schindler, Ralf Dieckmann, (unknown), (unknown), Klaus Unverferth	0
10	Phosphodiesterase 10A Inhibitor Activity in Preclinical Models of the Positive, Cognitive, and Negative Symptoms of Schizophrenia 2009 ·Journal of Pharmacology and Experimental Therapeutics ·Steven M. Grauer, Virginia Pulito, Rachel L. Navarra, Michy P. Kelly, Cody Kelley, Radka Graf, Barbara Langen, Sheree F. Logue, Julie Brennan, Lixin Jiang, Erik I. Charych, Ute Egerland, Feng Liu, Karen L. Marquis, Michael S. Malamas, Thorsten Hage, Thomas A. Comery, Nicholas J. Brandon	223
11	New GABA-modulating 1,2,4-oxadiazole derivatives and their anticonvulsant activity 2007 ·European Journal of Medicinal Chemistry ·Hans‐Joachim Lankau, Klaus Unverferth, Christian Grunwald, (unknown), (unknown), (unknown), Rita Dost, Ute Egerland, Chris Rundfeldt	64
12	Synthesis, Pharmacology, and Structure−Activity Relationships of Novel Imidazolones and Pyrrolones as Modulators of GABA_AReceptors 2006 ·Journal of Medicinal Chemistry ·Christian Grunwald, Chris Rundfeldt, Hans‐Joachim Lankau, (unknown), (unknown), Rita Dost, Ute Egerland, Hans–Jörg Hofmann, Klaus Unverferth	39
13	Characterization in Rats of the Anxiolytic Potential of ELB139 [1-(4-Chlorophenyl)-4-piperidin-1-yl-1,5-dihydro-imidazol-2-on], a New Agonist at the Benzodiazepine Binding Site of the GABAA Receptor 2005 ·Journal of Pharmacology and Experimental Therapeutics ·Barbara Langen, Ute Egerland, (unknown), Rita Dost, Klaus Unverferth, Chris Rundfeldt	29
14	Anti-Inflammatory Potential of the Selective Phosphodiesterase 4 Inhibitor N-(3,5-Dichloro-pyrid-4-yl)-[1-(4-fluorobenzyl)-5-hydroxy-indole-3-yl]-glyoxylic Acid Amide (AWD 12-281), in Human Cell Preparations 2004 ·Journal of Pharmacology and Experimental Therapeutics ·(unknown), Ute Egerland, Chris Rundfeldt	43
15	RNA-Based Drug Screening Using Automated RNA Purification and Real-time RT-PCR1 2004 ·SLAS DISCOVERY ·(unknown), Thorsten Hage, (unknown), Ute Egerland, Uwe Oelmüller, Kay Brune, Andreas Pahl	3
16	AWD 12-281 2002 ·Drugs of the Future ·(unknown), (unknown), Ute Egerland, (unknown), (unknown), Istvan Szelenyi, (unknown), (unknown), Martin Olbrich, (unknown), (unknown), (unknown), (unknown), Thomas Kronbach, (unknown)	5
17	Refolding, Purification, and Characterization of Human Recombinant PDE4A Constructs Expressed in Escherichia coli 2000 ·Protein Expression and Purification ·Wito Richter, Thomas Hermsdorf, Hauke Lilie, Ute Egerland, Rainer Rudolph, Thomas Kronbach, D Dettmer	12
18	1,5-Disubstituted Indazol-3-ols with Anti-Inflammatory Activity 1998 ·Archiv der Pharmazie ·(unknown), (unknown), (unknown), Wolfgang Sauer, Ute Egerland, (unknown), (unknown), Istvan Szelenyi, Bernhard Kutscher, Jürgen Engel	7
19	AWD-131-138 1998 ·Drugs of the Future ·A Rostock, C. Tober, Rita Dost, Chris Rundfeldt, (unknown), Ute Egerland, (unknown), (unknown), Thomas Kronbach, Hans‐Joachim Lankau, Klaus Unverferth, J. Engel	18
20	New 5-aminoacyl-5,10-dihydro-11H-dibenzo[b,e][1,4]diazepin-11-ones with antiarrhythmic activity. 1997 ·PubMed ·(unknown), (unknown), (unknown), Ute Egerland, William H. Sauer, (unknown), (unknown), (unknown)	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact